| 2021-02 | A narrative review of malnutrition in chronic liver disease | 전대원 |
| 2021-02 | NASH/liver fibrosis prevalence and incidence of non-liver comorbidities among people with NAFLD and incidence of NAFLD by metabolic comorbidites: Lessons from South Korea | 전대원 |
| 2014-11 | Necroptosis in Liver and Pancreatic Diseases | 전대원 |
| 2019-10 | Necroptosis signaling in liver diseases: An update | 전대원 |
| 2014-11 | Necroptosis: An emerging type of cell death in liver diseases | 전대원 |
| 2015-07 | NecroX-7 Ameliorate the Severity of Cerulein-Induced Acute Pancreatitis (CIP) Through Inhibition of Necroptosis/Necrosis via Reciprocal Regulation of Mitochondrial ROS and Proinflammatory Cytokines | 전대원 |
| 2020-03 | No Difference in Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection Treated With Entecavir Vs Tenofovir. | 전대원 |
| 2016-12 | Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment | 전대원 |
| 2013-07 | Novel cell-based assay reveals associations of circulating serum AhR-ligands with metabolic syndrome and mitochondrial dysfunction | 전대원 |
| 2017-12 | Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study | 전대원 |
| 2011-12 | Nutrition and chronic liver disease. | 전대원 |
| 2016-12 | An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys) TRACES Study | 전대원 |
| 2018-12 | Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting | 전대원 |
| 2021-02 | Optimal Hypoxic Preconditioning of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells (hES-MSCs) and Their Characteristics | 전대원 |
| 2014-11 | Osthol attenuates hepatic steatosis via decreased triglyceride synthesis not by insulin resistance | 전대원 |
| 2015-07 | Over-expression of HNF4 alpha attenuated lipotoxicity in non-alcoholic fatty liver disease model | 전대원 |
| 2012-05 | Percutaneous endoscopic gastrostomy using 10-cc syringe tubes for amyotrophic lateral sclerosis patients with limited mouth opening | 전대원 |
| 2014-03 | Pin1 induction in the fibrotic liver and its roles in TGF-beta 1 expression and Smad2/3 phosphorylation | 전대원 |
| 2020-11 | Pitch Processing Can Indicate Cognitive Alterations in Chronic Liver Disease: An fNIRS Study | 전대원 |
| 2018-12 | Presence of Sarcopenia and Its Rate of Change Are Independently Associated with Long-term Mortality in Patients with Liver Cirrhosis | 전대원 |
| 2015-11 | Prevalence of Gastric Subepithelial Tumors in Korea: A Single Center Experience | 전대원 |
| 2017-09 | Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States | 전대원 |
| 2020-02 | Prevalence of significant hepatic fibrosis using magnetic resonance elastography in a health check-up clinic population | 전대원 |
| 2019-12 | Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis | 전대원 |
| 2011-12 | Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction | 전대원 |
| 2014-01 | Prolonged N200 is the early neurophysiologic change in the patient with minimal hepatic encephalopathy | 전대원 |
| 2019-08 | Psoas muscle fluorine-18-labelled fluoro-2-deoxy-d-glucose uptake associated with the incidence of existing and incipient metabolic derangement | 전대원 |
| 2013-11 | Randomized clinical trial: Effects of multi-species probiotics on small intestinal bacterial overgrowth in patients with chronic liver disease- a placebo controlled study | 전대원 |
| 2019-04 | Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease | 전대원 |
| 2018-12 | Recent research trends and updates on nonalcoholic fatty liver disease | 전대원 |
